These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37567939)

  • 1. Serum ferritin level during hospitalization is associated with Brain Fog after COVID-19.
    Ishikura T; Nakano T; Kitano T; Tokuda T; Sumi-Akamaru H; Naka T
    Sci Rep; 2023 Aug; 13(1):13095. PubMed ID: 37567939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients.
    Bulla R; Rossi L; Furlanis G; Agostinis C; Toffoli M; Balduit A; Mangogna A; Liccari M; Morosini G; Kishore U; Manganotti P
    Front Immunol; 2023; 14():1191083. PubMed ID: 37398656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between brain fog, cardiac injury, and quality of life at work after hospitalization due to COVID-19.
    Chatys-Bogacka Ż; Mazurkiewicz I; Słowik J; Słowik A; Drabik L; Wnuk M
    Med Pr; 2024 Mar; 75(1):3-17. PubMed ID: 38523497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID.
    Chasco EE; Dukes K; Jones D; Comellas AP; Hoffman RM; Garg A
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From 'mental fog' to post-acute COVID-19 syndrome's executive function alteration: Implications for clinical approach.
    Pallanti S; Di Ponzio M; Gavazzi G; Gasic G; Besteher B; Heller C; Kikinis R; Makris N; Kikinis Z
    J Psychiatr Res; 2023 Nov; 167():10-15. PubMed ID: 37804756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
    Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC
    Front Immunol; 2023; 14():1147549. PubMed ID: 37187756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog.
    Kazama I
    Neurochem Res; 2023 Aug; 48(8):2345-2349. PubMed ID: 36952147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of complement immunity with brain fog in patients with long COVID.
    Hagiya H; Tokumasu K; Otsuka Y; Sunada N; Nakano Y; Honda H; Furukawa M; Otsuka F
    J Infect Chemother; 2024 Mar; 30(3):236-241. PubMed ID: 37866620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis.
    van der Feltz-Cornelis C; Turk F; Sweetman J; Khunti K; Gabbay M; Shepherd J; Montgomery H; Strain WD; Lip GYH; Wootton D; Watkins CL; Cuthbertson DJ; Williams N; Banerjee A
    Gen Hosp Psychiatry; 2024; 88():10-22. PubMed ID: 38447388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Lasting COVID-Associated Brain Fog: A Follow-Up Study.
    Asadi-Pooya AA; Shahisavandi M; Nemati H; Karimi A; Jafari A; Nasiri S; Mohammadi SS; Nemati M; Rahimian Z; Bayat H
    Eur Neurol; 2023; 86(3):166-170. PubMed ID: 36843124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the relationship between inflammatory biomarkers during COVID-19 hospitalization and subsequent long-COVID symptoms: A longitudinal and retrospective study.
    Sykes DL; Van der Feltz-Cornelis CM; Holdsworth L; Hart SP; O'Halloran J; Holding S; Crooks MG
    Immun Inflamm Dis; 2023 Oct; 11(10):e1052. PubMed ID: 37904690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID syndrome-associated brain fog.
    Asadi-Pooya AA; Akbari A; Emami A; Lotfi M; Rostamihosseinkhani M; Nemati H; Barzegar Z; Kabiri M; Zeraatpisheh Z; Farjoud-Kouhanjani M; Jafari A; Sasannia S; Ashrafi S; Nazeri M; Nasiri S; Shahisavandi M
    J Med Virol; 2022 Mar; 94(3):979-984. PubMed ID: 34672377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intervention modalities for brain fog caused by long-COVID: systematic review of the literature.
    Gorenshtein A; Liba T; Leibovitch L; Stern S; Stern Y
    Neurol Sci; 2024 Jul; 45(7):2951-2968. PubMed ID: 38695969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study.
    Chudzik M; Babicki M; Kapusta J; Kałuzińska-Kołat Ż; Kołat D; Jankowski P; Mastalerz-Migas A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and burden of acute COVID-19 and long-COVID: Demographic, physical, mental health, and economic perspectives.
    Leitner M; Pötz G; Berger M; Fellner M; Spat S; Koini M
    PLoS One; 2024; 19(1):e0297207. PubMed ID: 38252638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.
    Greene C; Connolly R; Brennan D; Laffan A; O'Keeffe E; Zaporojan L; O'Callaghan J; Thomson B; Connolly E; Argue R; Meaney JFM; Martin-Loeches I; Long A; Cheallaigh CN; Conlon N; Doherty CP; Campbell M
    Nat Neurosci; 2024 Mar; 27(3):421-432. PubMed ID: 38388736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Unusual Case of Blackout in a COVID-19 Patient: COVID-19 Brain Fog.
    Hassan L; Ahsan Z; Bint E Riaz H
    Cureus; 2023 Mar; 15(3):e36273. PubMed ID: 37073192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Brain fog', guilt, and gratitude: experiences of symptoms and life changes in older survivors 6 months after hospitalisation for COVID-19.
    Heiberg KE; Heggestad AKT; Jøranson N; Lausund H; Breievne G; Myrstad M; Ranhoff AH; Walle-Hansen MM; Bruun-Olsen V
    Eur Geriatr Med; 2022 Jun; 13(3):695-703. PubMed ID: 35267190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia.
    Papamanoli A; Kalogeropoulos AP; Hotelling J; Yoo J; Grewal P; Predun W; Jacob RP; Cao K; Marcos LA; Skopicki HA
    JAMA Netw Open; 2021 Oct; 4(10):e2127172. PubMed ID: 34605919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.